Intra-Cellular Therapies
ITCI
#1801
Rank
โ‚น768.70 B
Marketcap
โ‚น7,251
Share price
-0.36%
Change (1 day)
58.56%
Change (1 year)

EPS for Intra-Cellular Therapies (ITCI)

EPS in 2023 (TTM): -โ‚น132.73

According to Intra-Cellular Therapies's latest financial reports the company's current EPS (TTM) is -โ‚น135.39. In 2022 the company made an earnings per share (EPS) of -โ‚น228.73 an increase over its 2021 EPS that were of -โ‚น294.32.

EPS history for Intra-Cellular Therapies from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น132.73-41.97%
2022-โ‚น228.73-22.29%
2021-โ‚น294.328.02%
2020-โ‚น272.4520.9%
2019-โ‚น225.36-5.63%
2018-โ‚น238.8233.96%
2017-โ‚น178.27-21.19%
2016-โ‚น226.20-7.56%
2015-โ‚น244.70174.53%
2014-โ‚น89.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น21.02-84.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น840.91 521.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น179.95 32.92%๐Ÿ‡บ๐Ÿ‡ธ USA